| Neha Satyanarayana, MD | |
|
1105 Central Expy N Ste 2120, Allen, TX 75013-6117 | |
| (972) 727-9877 | |
| Not Available |
| Full Name | Neha Satyanarayana |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 1105 Central Expy N Ste 2120, Allen, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912355488 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 32292 (Oklahoma) | Primary |
| Entity Name | Family Healthcare Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831159466 PECOS PAC ID: 5496732307 Enrollment ID: O20040701000298 |
News Archive
In September 2009, the Kansas City District Office of the Food and Drug Administration (FDA) submitted a recommendation of approval to the Center for Drug Evaluation and Research for The University of Iowa Pharmaceuticals (UIP) to manufacture and test an aseptically filled, sterile prescription drug product for a commercial client. The drug product contains a new chemical entity and is a sterile solution that is aseptically filled into vials.
Researchers in the U.K. report that non-restorative sleep is the strongest, independent predictor of widespread pain onset among adults over the age of 50. According to the study published in Arthritis & Rheumatology (formerly Arthritis & Rheumatism), a journal of the American College of Rheumatology (ACR), anxiety, memory impairment, and poor physical health among older adults may also increase the risk of developing widespread pain.
Final year student in the University of Alicante's Multimedia Engineering degree Roberto Gómez has designed a football game adapted for people with cerebral palsy which is operated with a foot switch, a push rod head switch and a hand switch.
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today reported results from two ongoing Phase I studies with MLN9708, the first oral proteasome inhibitor being studied in patients with relapsed and/or refractory multiple myeloma.
Full information is desperately needed to assess the risks of a pandemic that in a worst-case scenario could claim tens of millions of lives worldwide says the United Nations health agency.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Neha Satyanarayana, MD 900 Ne 10th St, Fmc 2102, Oklahoma City, OK 73104-5420 Ph: (405) 271-2230 | Neha Satyanarayana, MD 1105 Central Expy N Ste 2120, Allen, TX 75013-6117 Ph: (972) 727-9877 |
News Archive
In September 2009, the Kansas City District Office of the Food and Drug Administration (FDA) submitted a recommendation of approval to the Center for Drug Evaluation and Research for The University of Iowa Pharmaceuticals (UIP) to manufacture and test an aseptically filled, sterile prescription drug product for a commercial client. The drug product contains a new chemical entity and is a sterile solution that is aseptically filled into vials.
Researchers in the U.K. report that non-restorative sleep is the strongest, independent predictor of widespread pain onset among adults over the age of 50. According to the study published in Arthritis & Rheumatology (formerly Arthritis & Rheumatism), a journal of the American College of Rheumatology (ACR), anxiety, memory impairment, and poor physical health among older adults may also increase the risk of developing widespread pain.
Final year student in the University of Alicante's Multimedia Engineering degree Roberto Gómez has designed a football game adapted for people with cerebral palsy which is operated with a foot switch, a push rod head switch and a hand switch.
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today reported results from two ongoing Phase I studies with MLN9708, the first oral proteasome inhibitor being studied in patients with relapsed and/or refractory multiple myeloma.
Full information is desperately needed to assess the risks of a pandemic that in a worst-case scenario could claim tens of millions of lives worldwide says the United Nations health agency.
› Verified 1 days ago
Dr. Astrid Gutsmann, DO, PH.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 411 E Mcdermott Dr, Allen, TX 75002 Phone: 972-227-3464 Fax: 972-359-9690 | |
Sovannarat Floyd, FNP-BC Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 906 W Mcdermott Dr Ste 124, Allen, TX 75013 Phone: 469-564-1026 | |
Dr. Sadaf Sadruddin Sabzali, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1650 E Stacy Rd Ste 160, Allen, TX 75002 Phone: 214-726-9098 Fax: 972-727-0842 | |
Dr. Nicholas Owon Kpar Atudonyang, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 977 Raintree Cir, Suite 210, Allen, TX 75013 Phone: 214-865-6648 Fax: 214-865-6646 | |
Wallace B Sarver, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1650 E Stacy Rd Ste 160, Allen, TX 75002 Phone: 214-726-9098 Fax: 972-727-0842 | |
Dr. Jeffrey L Burchard, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1105 Central Expy N, Ste 110, Allen, TX 75013 Phone: 972-727-9877 Fax: 972-727-5015 | |
Oyindamola Ojuolape Wemimo, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1218 W Mcdermott Dr, Allen, TX 75013 Phone: 972-390-9000 |